$1.03
0.03853.88%
Last update: Nov 9, 9:11 AM
Lisata Therapeutics Inc (LSTA) Stock Price, Quote, News & History
LSTANASDAQ
Lisata Therapeutics acquires Marea Therapeutics and secures $225 million in private financing for Phase 2 clinical trials.
You can purchase shares of Lisata Therapeutics (NASDAQ:LSTA) through any online brokerage.
Other companies in Lisata Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Lisata Therapeutics to provide a consensus price target.
The stock price for Lisata Therapeutics (NASDAQ: LSTA) is $1.1 last updated November 9, 2026 at 9:11 AM EST.
There are no upcoming dividends for Lisata Therapeutics.
Lisata Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Lisata Therapeutics.
Lisata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed...
